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ABSTRACT  
Objectives: To determine the frequency distribution of different cardiovascular disorders and to describe their 
associated morphological abnormalities by transesophageal echocardiography among patients referred to the 
Transesophageal Echocardiography Laboratory of Al-Thawrah General Hospital, Sana’a, in the period 2009–
2011. 
Methods: This was a retrospective descriptive study of 856 patients with suspected cardiovascular disorders 
and referred for transesophageal echocardiography over a two-year period. Data about patients’ sex, their refer-
ral site and transesophageal echocardiography findings were collected and analyzed according to the type of 
cardiovascular disorders, valvular affections and lesions, complications and recommended treatments. 
Results: Of the 856 patients, 63.4% were females and 36.6% were males. The majority of patients diagnosed by 
transesophageal echocardiography (82.4%) were referred from outpatient departments. Rheumatic heart dis-
ease was the most frequent cardiovascular disorder (87.1%), followed by tricuspid valve lesions (62.8%), of 
which 54% (329/606) were tricuspid regurgitation and 62.6% (114/182) were aortic valve regurgitation. Re-
garding the type of valvular lesions detected, mitral valve disease was the most frequent, being found in 69.2% 
(214/309) of patients. Regarding the severity of valvular lesions, 73.1% (19/26) of mitral valve stenosis cases 
were severe while 83.3% (35/62) of aortic stenosis cases were mild. Moderate pulmonary hypertension was 
seen mostly secondary to rheumatic heart disease. The majority of cardiovascular disorder patients (33.6%; 
284/844) were recommended for balloon mitral valvotomy. Mitral valve surgery was the most frequently per-
formed surgical intervention for affected valves of patients with cardiovascular disorders; being used for the 
treatment of 31.4% (80/255) of valvular lesions. 
Conclusions: Transesophageal echocardiography revealed that rheumatic heart disease is the most frequent 
cardiovascular disorder among Yemeni patients and poses a major health problem. In addition, a high propor-
tion of patients with cardiovascular disorders have valvular lesions of the mild degree that require surgical in-
tervention. 
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1. Introduction 
Cardiovascular disorders (CVDs) are a ma-
jor cause of morbidity and mortality worldwide 
(1–5). Economic and sociocultural changes con-
tribute to a considerable extent in the global 
impact of CVDs because these changes have re-
sulted in increased risk factors for CVDs (1–5). 
A major contribution to the dramatic increase 
in CVDs worldwide is attributed to the changes 
occurring in developing countries (1). 
In comparison to high-income countries, 
low- and middle-income countries (LAMIC) are 
the most afflicted with mortality rates because 
of CVDs, particularly among younger age 
groups (2–5). By 2020, annual estimates of 
about 6 million deaths and 35 million disability-
adjusted life years (DALYs) in developed coun-
tries compared to about 19 million deaths and 
170 million DALYs in developing countries may 
occur because of CVDs (6). 
The prevalence rate of coronary heart dis-
ease (CHD) is 4.1 per 1000 live births in Oman, 
3 per 1000 live births in Nigeria and 2 per 1000 
live births in Sudan, accounting for 3.9% of 
hospital admissions for CVDs; however, a high-
er prevalence rate of 11.5 per 1000 live births 
has been reported from Lebanon (7). CVDs are 
responsible for about 12.4% of all deaths in 
Yemen in 1970 compared to 47% of deaths in 
1998. However, there is a lack of data on heart 
failure in Yemen (8). 
Rheumatic heart disease (RHD) and conse-
quent valvular diseases are very common in 
LAMIC, including Yemen, with social, economic 
and medical consequences (5, 9–13). Mitral re-
gurgitation (MR) is the most common cardiac 
manifestation while obstructive valvular dis-
ease is distinctly rare in under five-year-old age 
groups (14). In Africa, RHD represents a major 
health problem that predominantly affects fe-
males more than males (with a ratio of 13:4), 
necessitating appropriate early detection to-
gether with other general preventive programs 
(12). RHD and its valvular affection are still epi-
demic in Asia not only due to the limited availa-
bility of penicillin but also due to their poor so-
cioeconomic conditions such as overpopulation, 
overcrowding, poverty and poor access to medi-
cal care (15). The prevalence rate of RHD among 
Yemeni children was reported to be 36.5/1000, 
with MR being detected in 49% and combined 
MR and aortic regurgitation (AR) in 17.8% of 
children (16). In southern Yemen governorates, 
females were affected with RHD more than 
males (52.4% and 47.6%, respectively). Valvular 
damage, especially regurgitation, was commonly 
found in the mitral valve; mainly due to a single 
lesion. However, pulmonary hypertension (PH) 
was the most common complication of RHD, be-
ing detected in 80.4% of patients (17). 
Early detection is thus highly needed to 
maximize case detection of subclinical RHD in 
LAMIC (18, 19). Auscultation of the heart for 
early diagnosis of RHD lacks sensitivity and 
specificity while transesophageal echocardiog-
raphy (TEE) of the heart is a feasible and excel-
lent non-invasive method for assessing heart 
structure, function and hemodynamic status (18, 
20). Moreover, TEE improves the case detection 
rate of RHD to up to ten times greater than clini-
cal examination alone (5, 18, 20–23). Given that 
TEE improves the detection of subclinical RHD, 
and therefore prevents the progress of disease, 
there is a need for the evidence-based criteria 
for TEE-based diagnosis. Therefore, subclinical 
valvular lesions should be considered as possi-
ble RHD until confirmed otherwise, and second-
ary rheumatic fever prophylaxis is recommend-
ed to affected children (1, 4, 18, 20, 22, 24). TEE 
was first applied to evaluate the left ventricular 
(LV) size and function. Echocardiographic de-
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termination of global and regional LV function 
has witnessed great improvements (3, 4, 25). 
The introduction of TEE to the operating 
room is effective for the clinical follow-up and 
hemodynamic management of patients under-
going general anesthesia and during cardiac 
procedures (26). Secondary prevention by the 
early detection of subclinical rheumatic heart 
disease by TEE is vital and has important public 
health implications. Moreover, it can potentially 
prevent their progression to serious valve dis-
eases (4, 5, 22, 27, 28). 
In Yemen, the use of TEE in the diagnosis 
and follow-up of acute rheumatic fever and for 
the secondary prevention of subclinical cardiac 
disease has not been reported yet. However, the 
clinical impact of TEE is not well defined, with 
scarcity of available data about its benefit in 
screening and early case detection (21, 24, 29–
31). In contrast to other non-communicable 
diseases, only a very few multi-center trials on 
the application of TEE have been performed. 
Thus, the limitation of routine TEE use could be 
attributed to the current inadequacy of out-
come data, the absence of training facilities and 
its high cost. In this study, we aimed to deter-
mine the frequency of CVDs as detected by TEE, 
to describe their morphological abnormalities 
and to formulate recommendations on their 
management. 
 
2. Methods 
The present study was a retrospective 
search through all medical files of adult patients 
clinically diagnosed as CVD cases and referred 
to the TEE Laboratory of the Non-invasive Di-
agnostic Cardiac Unit of Al-Thawrah General 
Hospital (AGH), Sana'a, in the period from Jan. 
2009 to Jan. 2011. It is the only unit for referral 
of cases from the outpatient departments 
(OPDs) and inpatient departments (IPDs) and 
even from other hospitals in the country. A total 
of 856 medical records of adult patients with 
CVDs, who underwent TEE, were included and 
strictly reviewed. CVD cases were identified 
based on the diagnosis by the attending physi-
cians during patients' discharge from the unit. 
The TEE assessment is done according to the 
American Association for Heart Diseases Criteria 
(32). 
Patients who were diagnosed for the first 
time using TEE were only included in this study. 
The exclusion criteria included patients with 
significant valvular heart disease. The data de-
rived from patients' medical files including sex, 
TEE findings and TEE recommendations were 
entered into computer by the investigators 
themselves who made the TEE investigations. 
Data were then analyzed using SPSS version 10 
(SPSS, Inc., Chicago, IL, USA). In this study, the 
valvular lesion disease was defined as an in-
flammatory valvular lesion due to endocarditis 
while other valvular lesions such as valvular 
stenosis and regurgitation were defined as mal-
formations of the valve or congenital anomalies.  
Ethical considerations: An ethical approval 
was obtained from the hospital administration 
prior to the study. Patients’ data were treated 
without names and kept confidentially.  
 
3. Results 
3.1. Referral site and sex of CVD patients 
Out of 856 patients admitted to the TEE unit 
in the period from Jan. 2009 to Jan. 2011, 82.5% 
were referred from the OPDs compared to 
17.5% from the IPDs. Males represented 63.4%, 
while females represented 36.6% of the total pa-
tients with CVDs admitted to the TEE unit. 
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3.2. CVD patterns of patients as diagnosed by 
TEE 
Table (1) shows the different patterns of CVDs 
as diagnosed by TEE among patients referred to 
the TEE Laboratory of the AGH during the peri-
od of the study. Of the total number of referred 
cases, 98.6% of patients showed CVDs whereas 
1.4% of patients were normal by TEE. RHD was 
the most predominant clinical pattern, being 
present among 87.1% of referred CVD patients. 
Those with congestive heart failure represent-
ed only 7.2% of the total number of referred 
cases, with minimal, comparable percentages of 
about 2.0% being observed in patients with PH 
and other CVDs. 
Table 1. Frequency distribution of CVD patients by TEE diagnosis 
in AGH, Sana’a (2009–2011) 
Cardiovascular disorders No. (%)* 
Rheumatic heart disease 745 (87.1) 
Congestive heart failure 62 (7.2) 
Pulmonary hypertension 20 (2.3) 
Other cardiovascular dysfunctions 17 (2.0) 
Total 844 (98.6) 
*12 patients (1.4%) were normal. 
 
3.3. Types of valves affected in CVD patients 
as diagnosed by TEE 
Table (2) shows the types and frequency distri-
bution of affected valves as diagnosed by TEE 
among the 844 CVD patients with valvular ab-
normalities. The majority of patients (62.8%) 
had triple valve damage followed by those hav-
ing a combined damage in the mitral and aortic 
valves (21.0%). The combined damage in the 
mitral and tricuspid valves was present in 9.0% 
of patients while the damage to the mitral valve 
alone was present in only 6.6% of patients. The 
least affected valve among patients with valvu-
lar abnormalities was the aortic valve, with on-
ly less than 1.0% of patients showing damage in 
this type of valve. 
Table 2. Frequency distribution of affected valves of CVD patients 
diagnosed by TEE in AGH, Sana’a (2009–2011) 
Affected valve No. (%) 
Triple valve 530 (62.8) 
Mitral and aortic valves 177 (21.0) 
Mitral and tricuspid valves 76 (9.0) 
Mitral valve 56 (6.6) 
Aortic valve 5 (0.6) 
Total 844 (100.0) 
 
3.4. Valvular lesion distribution according to 
the type of valve affected as diagnosed by TEE 
Table (3) shows the distribution of different 
types of valvular lesions according to the type of 
affected valve(s) as diagnosed by TEE among pa-
tients with valvular abnormalities. The mitral 
valve disease was the most frequent condition 
among patients with valvular abnormalities, 
with 69.2% of patients showing this type of val-
vular lesion. However, mitral stenosis (MS) was 
present among only 8.0% of patients. Regarding 
the aortic valve, aortic stenosis (AS) and regur-
gitation were the most frequent types of lesions, 
being 23.1% and 62.6%, respectively. On the 
other hand, the most frequent lesions in the tri-
cuspid valve were the tricuspid regurgitation 
(54.0%) and the tricuspid valve disease 
(46.0%). 
Table 3. Frequency distribution of valvular lesions according to 
the types of affected valves among CVD patients diagnosed by TEE 
in AGH, Sana’a (2009–2011) 
*Some patients had more than one valvular lesion. 
Type of val-
vular lesions 
Type of valve affected* No. (%) 
Mitral 
valve 
(n=309) 
Aortic 
valve 
(n=182) 
Tricuspid 
valve 
(n=606) 
Disease 214 (69.2) 16 (8.8) 279 (46.0) 
Stenosis 26 (8.0) 42 (23.1) 0 (0.0) 
Post-surgery 
repair 
35 (11.3) 10 (5.5) 0 (0.0) 
Regurgitation 34 (11.0) 114 (62.6) 329 (54.0) 
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3.5. Valvular lesion distribution according to 
their severity as diagnosed by TEE 
Table (4) shows the distribution of valvular le-
sions among patients by their grades of severity 
as diagnosed by TEE. Regarding the mitral valve 
lesions, most MS cases (73.1%) were severe, 
with the moderate-to-severe and mild cases 
representing 19.2% and 7.7% of cases, respec-
tively. In contrast, more than a half of MR, AS 
and AR cases were of the mild type, being 
58.8%, 83.3% and 45.5%, respectively (Table 
4).  
Table 4. Frequency distribution of valvular lesions by the grade 
of severity among CVD patients diagnosed by TEE in AGH, Sana’a 
(2009–2011) 
Valvular 
lesion* 
Grades of severity No. (%) 
Mild 
Moderate 
to severe 
Severe 
Mild to 
moderate 
Moderate 
Mitral stenosis 
2 
 (3.2) 
5 
(45.5) 
19 
 (73.1) 
0 
(0.0) 
0 
(0.0) 
Mitral re-
gurgitation 
20  
(32.2) 
4 
(36.4) 
3 
(11.5) 
5 
(55.5) 
2 
(40) 
Aortic stenosis 
35  
(56.5) 
1 
(9.1) 
3 
 (11.5) 
1 
(11.1) 
2 
(40) 
Aortic re-
gurgitation  
5 
 (8.1) 
1 
(9.1) 
1 
(3.8) 
3 
(33.3) 
1 
(20) 
Total 62 11 26 9 5 
*Some patients had more than one valvular lesion. 
 
3.6. Management recommendations for CVD 
patients diagnosed by TEE 
Table (5) presents the different management 
recommendations for CVD patients. All CVD pa-
tients diagnosed by TEE were recommended 
for another line of treatment. The majority of 
patients were recommended for balloon mitral 
valvotomy (BMV) and valvular surgical inter-
vention; being recommended for 33.6% and 
30.2% of them, respectively. Follow-up option 
and a two-month anticoagulant therapy were 
recommended for 19.8% and 16.4% of patients, 
respectively. 
Table 5. Frequency distribution of recommendations for man-
agement of CVDs diagnosed by TEE in AGH, Sana’a (2009–2011) 
Recommendation No. (%) 
Balloon mitral valvotomy 284 (33.6) 
Surgery 255 (30.2) 
Follow-up 167 (19.8) 
Two-month anticoagulant therapy 138 (16.4) 
Total 844 (100) 
 
3.7. Surgical interventions adopted for 
affected valves as diagnosed by TEE 
Table (6) shows the frequency of different sur-
gical interventions adopted for treating the af-
fected valves of CVD patients with valvular le-
sions. Mitral valve surgery was the most fre-
quent intervention, being performed for treating 
31.4% of valve lesions. This was followed by 
corrective surgery and double-valve replace-
ment (DVR), being performed in 20.4% and 
18.4% of valves, respectively. Mitral valve 
thrombectomy was the least performed inter-
vention, being used in 4.3% of valves.  
Table 6. Frequency distribution of affected valves by surgical 
intervention of CVD patients diagnosed by TEE in AGH, Sana’a 
(2009–2011) 
Surgical intervention 
Affected valves (n = 255) 
No. (%) 
MV surgery 80 (31.4) 
Corrective surgery 52 (20.4) 
DVR 47 (18.4) 
MV/TV repair 24 (9.4) 
DVR/TV repair 22 (8.6) 
AV surgery 19 (7.5) 
MV thrombectomy 11 (4.3) 
Total 255 (100) 
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4. Discussion 
RHD is an important health problem in de-
veloping countries, including Yemen, and can 
cause permanent functional and morphological 
impairment (1–7). Some researchers have sug-
gested that up to 90% of patients may be pre-
sented with valvular insufficiency even in the 
absence of clinical signs. In contrast, MR and AR 
are more likely due to RHD in endemic areas (5, 
13, 21, 28–30, 32). They suggested that the 
most effective preventive method for control-
ling CVD is secondary prevention by using TEE, 
where it can also avoid both over- and under-
diagnosis of cardiac diseases. Therefore, TEE 
should be used as a diagnostic criterion for bet-
ter visualization of the vegetation shape and 
size in addition to the adjacent tissues, severity 
of valvular regurgitation and associated hemo-
dynamic states (3, 13, 27, 28, 31, 32). Our study 
reveals that adult females were more prone to 
develop CVD, which is probably due to an in-
crease in their susceptibility and exposure to 
group A β-hemolytic Streptococcus infection of 
the throat; a finding that has been observed in 
other countries (15, 32). 
Patients referred to the TEE unit were 
mostly from the OPDs, suggesting that they 
were probably new cases that had not been 
confirmed yet. Most patients with CVDs diag-
nosed by TEE had RHD complicated with valvu-
lar lesions and prominently mild AR, which 
were suggestive of greater rheumatic activity 
processes (29, 30). 
Our results are in agreement with the find-
ings of previous studies (7, 15, 28). Tricuspid 
valve insufficiency was involved in the great 
majority of patients with CVD. Tricuspid regur-
gitation is the result of the dilatation of the 
right ventricle following the PH that compli-
cates MS. Other studies (5, 19, 23–25, 27, 28) 
had drawn different conclusions from those in 
our study regarding the type of valve most af-
fected, which is the mitral valve. This difference 
is probably due to the different methods for di-
agnosing cardiac disease rather than to the dif-
ferences in the personal characteristics or to the 
place and time of the study initiation. In our 
study, most cases appeared to be at a lower risk 
for developing valvular abnormalities, but the 
mitral valves were permanently affected. 
In the present study, PH did not have an im-
portant role in the patients' conditions, except 
for its complications. In fact, PH is considered a 
serious outcome of CVD, and prevention of its 
complications is a major principle of manage-
ment (27). Most patients in our study had mod-
erate PH that was mostly combined with RHD. 
These findings were consistent with what has 
been reported in the literature (27). The partici-
pants were mostly recommended for invasive 
BMV and mitral valve surgical treatment. This is 
in agreement with previous studies (27, 32). 
5. Conclusions 
TEE diagnosis of Yemeni patients with CVDs 
reveals that females are more prone to RHD and 
valvular dysfunctions, particularly aortic valve 
insufficiency. PH was quite common while val-
vular vegetation was uncommon in patients 
with CVDs. The present study also reveals that 
patients with RHD frequently require BMV and 
non-surgical treatment. Therefore, TEE criteria 
should be considered for detecting subclinical 
CVD. It should be compared with alternative 
treatment strategies in prospective randomized 
studies. TEE is recommended to assess echocar-
diographic features in suspicious clinical situa-
tions. 
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